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Summary. Papillary thyroid carcinomas (PTCs) have 
characteristic nuclear shape changes compared to 
follicular-type thyroid epithelium. We tested the 
hypothesis that the altered nuclear shape results from 
altered distribution or expression of the major structural 
proteins of the nuclear envelope. Lamin A, lamin B1, 
lamin C, lamin B receptor (LBR), lamina-associated 
polypeptide 2 (LAP2), emerin, and nuclear pores were 
examined. PTC7s with typical nuclear features by H&E 
were compared to non-neoplastic thyroid and follicular 
neoplasms using confocal microscopy, and semi- 
quantitative immunoblotting. Lamin A/C, lamin B1, 
LAP2, emerin, and nuclear pores al1 extend throughout 
the grooves and intranuclear inclusions of PTC. Their 
distribution and fluorescent intensity is not predictably 
altered relative to nuclear envelope irregularities. By 
immunoblotting, the abundance (per cell) and 
electrophoretic mobilities of lamin A, lamin B1, lamin 
C, emerin, and LAP2 proteins do not distinguish PTC, 
normal thyroid, or follicular neoplasms. These results do 
not support previously published predictions that lamin 
A/C expression is related to a loss of proliferative 
activity. At least three LAP2 isoforms are identified in 
normal and neoplastic thyroid. LBR is  sparse or  
undetectable in al1 the thyroid samples. The results 
suggest that the irregular nuclear shape of PTC is not 
determined by these nuclear envelope structural proteins 
per se. We review the structure of the nuclear envelope, 
the major factors that determine nuclear shape, and the 
possible functional consequences of its alteration in 
PTC. 
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lntroduction 
Normal thyroid epithelium can be transformed via 
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two different pathways. The two pathways lead to 
papillary thyroid carcinoma (PTC) or  follicular 
neoplasms. Papillary thyroid carcinoma is diagnosed 
largely on the basis of nuclear contour changes and 
changes in heterochromatin texture (Vickery et al., 
1985). Both normal thyroid cel ls  and follicular 
neoplasms tend to have rigidly spherical nuclear 
contours, and they generally have block-like aggregates 
of heterochromatin apposed to the nuclear envelope. In 
contrast, typical papillary thyroid carcinomas have fine, 
rather than block-like heterochromatin, and they exhibit 
frequent buckling of their nuclei with characteristic 
grooves and occasional rounded nuclear envelope 
invaginations temed intranuclear cytoplasmic inclusions 
(Rosai et al., 1992). The nuclear contour changes of 
papillary thyroid carcinoma can be appreciated in non- 
fixed living cel ls  (AH Fischer, unpublished 
observations), after formalin, alcohol or air drying 
fixation, and by electron microscopy (Johannessen et al., 
1983; Oyama, 1989; LiVolsi, 1990). The papillary 
thyroid carcinoma oncogene (RET/PTC), is active early 
in the formation of PTCs (Viglietto et al., 1995;  
Klugbauer et al., 1998), and appears sufficient to 
mediate the changes in nuclear envelope contour and 
heterochromatin characteristic of PTC (Fischer et al., 
1998a). In contrast, activation of RAS (a frequent early 
event in the genesis of follicular neoplasms; Lemoine et 
al., 1989; reviewed in Wynford-Thomas, 1997), leaves 
the nucleus round and coarsens heterochromatin when 
expressed in either normal thyroid (Fischer et al., 1998a) 
or fibroblast cells (Fischer et al., 1998b). 
A precise molecular understanding of the 
morphologic changes in cancer cell nuclei is a rational 
means of improving diagnosis.  PTC provides an 
excellent model system. Since many forms of cancer 
besides PTC show nuclear contour abnormalities (Frost, 
1986), a biochemical characterization of the nuclear 
contour changes could have broad diagnostic utility. In 
addition, defining the nuclear contour changes in 
biochemical terms would facilitate studies of the 
apparently divergent signaling pathways downstream of 
RET/PTC and RAS in the thyroid. 
Nuclear contour i s  defined by the large scale 
Papillary thyroid carcinoma nuclear envelope 
organization of the nuclear envelope. The nuclear 
envelope includes four major structural elements: the 
nuclear lamina, inner nuclear membrane, outer nuclear 
membrane, and nuclear pore complexes (reviewed in 
Gerace and Foisner, 1994; Moir et al., 1995; Gant and 
Wilson, 1997; Ohno et al., 1998). The nuclear lamina is 
situated between the inner nuclear membrane and 
chromatin; some of the proteins of the nuclear lamina 
are also present in the interior of the nucleus. In most 
cells, the peripheral nuclear lamina is too thin to be 
resolved by routine transmission electron microscopy. 
The nuclear lamina is a flexible, elastic yet strong 
(Maniotis et al., 1997;  Heidemann e t  al. ,  1999) 
meshwork of protein fibers, composed primarily of 
polymerized nuclear-specific type V intermediate 
filament proteins called lamins. The abundance of the 
filamentous lamins has suggested a role in determining 
nuclear shape (reviewed in Moir et al., 1995). 
Accordingly, altered expression, or expression of mutant 
lamins can affect nuclear contour (Loewinger and 
McKeon, 1988; Furukawa and Hotta, 1993; Ellis et al., 
1997; Lenz-Bohme et al., 1997). There are two classes 
of lamins. The A-type lamins include lamins A and C 
(-72 and 62 kD) which arise from differential splicing of 
the same transcript,  followed by different post- 
translational modifications (reviewed by Moir et al., 
1995). Expression of lamins A and C appears to be 
regulated at the leve1 of both transcription and mRNA 
stability (Lanoix et al., 1992). There are two known 
human B-type lamin genes, named lamin B1 and B2. Al1 
mammalian cells express one or both of these lamins. 
Lamin B2 is known to be widely expressed, except in 
hepatocytes (Broers et al., 1997). The expression of 
lamins in PTC has not been studied. 
The  s table assembly of lamins a t  the nuclear 
periphery may be mediated by their binding to severa1 
relatively abundant integral membrane proteins restricted 
to the inner nuclear membrane (reviewed in Georgatos et 
al., 1994; Gerace and Foisner, 1994; Gant and Wilson, 
1997). Since some of these membrane proteins also bind 
to chromatin, they are obvious candidates for mediating 
the large-scale changes in nuclear envelope and 
chromatin organization of PTC. The lamin B receptor or 
LBR (-58 kd) was so named because it binds lamin B 
with high affinity and is present at high concentration in 
the avian erythrocyte nuclear envelopes in which it was 
first characterized (Worman et al., 1988; reviewed in Ye 
et al., 1998). The tissue distribution of human LBR is 
incompletely characterized. LBR also may help organize 
large-scale chromatin distribution and transcription since 
it binds to a heterochromatin protein called Hpl  (Ye and 
Worman, 1996; Ye et al., 1997). Hp l  was originally 
identified as a mediator of position effect variegation in 
Drosophila, helping repress transcription. LBR may also 
function to target mitotic nuclear envelope vesicles back 
to the surface of chromosomes during post-mitotic 
nuclear envelope re-assembly (Pyrpasopoulou et al., 
1996). 
TWO unrelated lamin-associated polypeptides 
(LAPs), named LAPl and LAP2, both have high affinity 
for lamin B (Foisner and Gerace, 1993). LAPl may also 
bind weakly to lamins A/C (Foisner and Gerace, 1993; 
reviewed in Gerace and Foisner, 1994). The function and 
distribution of LAPl is not well-characterized. More is 
known about LAP2, a protein with distinct chromatin 
and lamin B binding domains (Foisner and Gerace, 
1993; Yang et al., 1997). LAP2 may bind chromatin via 
a small DNA-binding protein of unknown function 
named Barrier to Autointegration Factor (BAF) (Lee and 
Craigie, 1998; Furukawa, 1999). Humans express at 
least three major splicing isoforms of LAP2, named a, B, 
and y (Harris et al., 1995; Berger et a!.,. 1996) and 
possibly four minor isoforms, as identified in mice 
(Berger et al., 1996). LAP2 isoforms appear to regulate 
lamina re-assembly and nuclear envelope expansion after 
mitosis (Yang et al., 1997; Gant et al., 1999). The largest 
LAP2 isoform, LAP2a (-75 kD), lacks a membrane 
spanning domain, and behaves biochemically as  a 
component of the nuclear matrix by resisting extraction 
with detergent, nuclease and salt (Dechat et al., 1998). 
The status of LAP2 proteins has not been studied in 
relation to tumorigenesis, and it is not known if they are 
present in the thyroid. 
Related to LAP2, and also located on the inner 
nuclear membrane, are two additional proteins named 
emerin (Manilal et al., 1996) and MANl  (Paulin- 
Levasseur et al., 1996). Emerin was discovered because 
its loss causes the X-linked hereditary syndrome Emery- 
Dreifuss muscular dystrophy (EDMD), characterized 
clinically by contactures, slowly progressive muscle 
wasting, and cardiac conduction defects (Emery, 1989; 
reviewed in Morris and Manilal, 1999; Wilson, 2000). 
Emerin is widely expressed, but its presence in the 
thyroid has not been documented (Manilal et al., 1996). 
Curiously, an autosomal dominant form of EDMD, 
which has the same range of clinical symptoms as the X- 
linked form, is caused by dominant mutations in the 
lamin A/C gene (Bonne et al., 1999), suggesting possible 
overlapping functions downstream of these proteins. The 
mechanism by which loss of emerin or lamin A/C causes 
delayed degenerations in only certain cell types is not 
yet known. Emerin appears to interact with the lamina or 
chromatin (Manilal et al., 1996; reviewed in Wilson, 
2000). Very little is yet known about the recently cloned 
MANl gene (Paulin-Levasseur et al., 1996; H. Worman, 
personal communication). 
The outer nuclear envelope faces the cytoplasm and 
is proposed to interact with the cytoskeleton, although 
very little is known about the molecular basis for the 
interaction (Goldman et al., 1985; Georgatos and Blobel, 
1987; Albers and Fuchs, 1989). The outer nuclear 
membrane is  continuous with the endoplasmic 
reticulum. The inner and outer nuclear membranes join 
at the nuclear pore complexes. Nuclear pore complexes 
are bound to the nuclear lamina, perhaps via attachment 
with lamins (Dwyer and Blobel, 1976; Lenz-Bohme et 
al., 1997). An electron micrograph study demonstrated 
that the total number of nuclear pore complexes per cell 
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is decreased in PTCs even though the surface area of the 
nuclear envelope in PTCs was greater than in follicular 
samples (Johannessen et al., 1982). The distribution of 
nuclear pore complexes relative to grooves and 
inclusions has not been described. 
The purpose of the present study was to broadly 
survey the organization of the nuclear envelope in PTC 
cells, and test the hypothesis that changes in the 
expression or distribution of the major nuclear envelope 
proteins are responsible for the diagnostic nuclear 
contour irregularity of PTC. Specifically, we asked if 
there was a predictable absence or over-expression of 
any of the major nuclear envelope structural proteins in 
the landmark grooves and inclusions in PTC. We also 
asked if the electrophoretic mobilities or relative 
abundance of lamins A, B1, C, LBR, LAP2 isoforms, or 
emerin were altered in PTC relative to control tissues. 
Materials and methods 
Cases studied 
The source of material for these studies was excess 
tissue not needed for diagnosis from surgically resected 
human thyroids, as approved by the Emory Human 
Investigations Committee. Table 1 lists the cases studied. 
Classification (by A. H. F.) follows the Armed Forces 
Institute of Pathology Fasicle (Rosai et al., 1992). By 
hematoxylin and eosin staining, the 14 PTCs al1 showed 
typical diagnostic nuclear features including nuclear 
contour irregularity, grooves and inclusions. Table 1 
shows the tumor size, nodal status, and presence of 
metastatic disease (TNM status) (Beahrs et al., 1992) at 
the time the tissue was procured. 'Ifirelve of the 14 were 
"differentiated" and showed typical dispersed chromatin 
(Rosai et al., 1992). One of these twelve (PTC-9) had 
dedifferentiated in another area into an anaplastic thyroid 
carcinoma. l k o  tal1 cell variants of PTC were included. 
Follicular thyroid samples with typical relatively round 
nuclear contours by hematoxylin and eosin staining, 
served as controls. These follicular thyroid samples 
included adjacent normal thyroid tissue from three 
patients (without lymphocytic thyroiditis or nodular 
change), three follicular adenomas, one angio-invasive 
oncocytic carcinoma (Hurthle cell carcinoma), one 
angio-invasive well-differentiated follicular carcinoma, 
and four poorly differentiated follicular carcinomas. We 
classify these four poorly differentiated carcinomas as 
follicular-type neoplasms (Rosai et al., 1992) due to a 
combination of an absence of the nuclear features of 
PTC, absence of papillary architecture, and 
predominance of venous invasion over lymphatic 
invasion. Three of these are subclassified as  insular 
carcinomas. One "well-differentiated thyroid carcinoma 
not otherwise specified" was diagnosed according to 
criteria in (Rosai et al., 1992). This tumor showed 
partially developed nuclear morphologic changes of PTC 
but was entirely follicular in architecture, was  
encapsulated, and showed venous but not lymphatic 
invasion. 
Fixation for immunofluorescence staining 
Smears from the tumors or non-neoplastic thyroid 
were prepared by scraping the surface with one 
microscope slide, smearing the sample on a second slide, 
and immediately immersing in either 95% alcohol (Flex, 
Richard Allen, Kalamazoo, MI) or 10% normal buffered 
formalin (NBF) (Biochemical Sciences, Inc., 
Swedesboro, NJ) at room temperature. Smears were held 
indefinitely in 95% alcohol at 4 degrees before 
immunostaining. For NBF fixation, smears  were 
transferred out of room temperature NBF after 15  
minutes fixation and held at 4 degrees in phosphate 
buffered saline (PBS) for up to one week. 
Antibodies 
Rabbit polyclonal antibodies to lamin A/C and lamin 
B1 were a kind gift of Dr. Nilhabh Chaudhary. The 
lamin A/C antibody was raised against amino acids 413- 
426 of the human lamin A/C gene, corresponding to an 
epitope shared by both lamins A and C. The lamin B1 
antibody was raised against amino acids 411-424, 
specific to human larnin B1. These antibodies have been 
previously characterized (Chaudhary and Courvalin, 
1993; Hytiroglou et al., 1993), and were confirmed on 
immunoblots for this study: each sera specifically 
recognized proteins of the appropriate molecular weight 
that co-purify with hepatocyte and normal thyroid 
nuclear envelopes, prepared as described by Dwyer and 
Blobel, 1976. Both lamin antibodies were used at 
dilutions of 1:50 for immunofluorescence and 1:1000 for 
irnmunoblotting. A monoclonal mouse antibody reactive 
with emerin, clone 4G5 (Novo Castra laboratories, New 
Castle upon Tyne, UK) was used at 1:500 for 
immunofluorescence and 1:5000 for immunoblots. A 
mouse monoclonal antibody recognizing nuclear pore 
proteins, Mab414 (Berkeley Antibody Company, 
Richmond CA), was  diluted 1:500 for  immuno- 
fluorescente. Immunostaining of alcohol-fixed material 
could not be achieved with the 414 antibody. Therefore, 
al1 nuclear pore immunostaining was performed on 
formalin fixed smears. An affinity purified rabbit 
polyclonal antibody raised against the N-terminus of the 
human lamin B receptor (Ye and Worman, 1996), a 
generous gift  of Dr. Howard Worman, Columbia 
University, was  used a t  1:500 dilution for  
immunoblotting. A polyclonal antiserum against human 
LAP2 was raised by immunizing rabbit #2804 with a 
bacterially-expressed purified His-tagged polypeptide 
consisting of N-terminal amino acids 1-187 of human 
LAP2. These amino acids are present in al1 three known 
human isoforms of LAP2 (Harris et al., 1995) and al1 
seven mouse isoforms (Berger et al., 1996). Thus, the 
antibody is expected to detect al1 known isoforms of 
LAP2. This expectation was confirmed on immunoblots; 
serum #2804 reacted specifically with three major 
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proteins of the expected molecular weight (-76, 54, and 
38 kD) from hepatocyte nuclei, and specifically stained 
the nuclear periphery by indirect immunofluorescence. 
Whole serum was used at dilutions of 1:10,000 for 
imrnunoblotting and 1:500 for immunofluorescence. Pre- 
immune serum from the same rabbit was totally non- 
reactive in paired control immunoblots and immuno- 
fluorescence experiments, even when used at 
concentrations ten times higher than immune serum. 
Secondary antibodies for immunofluorescence 
(Jackson Immunoresearch Laboratory, West Grove, PA) 
included fluorescein isothiocyanate (FITC) conjugated 
goat anti-mouse Fab fragments (14 pglml), FITC- 
conjugated goat anti-rabbit whole IgG (15 pg/ml), Cy3 
Donkey anti-rabbit Fab fragments (2.8 pg/ml), and Cy3 
sheep anti-mouse Fab fragments (2.6 pglml). For 
immunoblotting, secondary antibodies (Amersham Life 
Sciences, Jackson Heights, IL) included horseradish 
peroxidase conjugated donkey anti-rabbit antibody at 
1:1000 dilution, and horseradish peroxidase conjugated 
sheep anti-mouse antibody at 1:3000 dilution. 
lmmunofluorescence staining protocol 
Smears were rinsed or rehydrated with PBS, then 
cells were permeabilized with 0.5% triton X-100 
(Sigma) in PBS for 15 minutes at room temperature and 
rinsed three times with PBS. A 20 minute incubation at 
room temperature with 10% fetal calf serum (FCS) 
(Atlanta Biologicals,  Norcross, GA) in PBS was 
performed to block non-specific binding. 100 p l  of 
primary antibody diluted into 10% FCS in PBS was 
layered onto the smears and covered with a glass 
coverslip for 1 hour at room temperature. Three washes 
with PBS was followed by incubation for 30 minutes at 
room temperature with 100 pl of fluorescent secondary 
antibody in PBS with 1% FCS. Three washes with PBS 
was followed by incubation for 15 minutes in 10 pg/ml 
propidium iodide in PBS at room temperature for most 
sarnples. After three final washes in PBS, smears were 
coverslipped with DAKO Fluorescent Mounting 
Medium (Carpenteria, CA). 
Confocal microscopy 
A Zeiss LSM 410 Confocal microscope with an 
ArgonKrypton laser was used to capture images using 
non-overlapping FITC (green, or yellow if superimposed 
on red) and propidium iodide or Cy3 (red) detection 
channels. A Zeiss 100 X oil immersion plan apochromat 
lens with a numerical aperture of 1.4 was used with a 
zoom setting of 3 for final magnification of 3000X. 
Pinhole settings of 18 were used, corresponding to a Z- 
plane thickness of 0.5 microns. For most work, serial 
images in the X-Y plane were collected at a spacing of 1 
micrometer. 
Cell fractionation and immunoblotting 
Al1 samples examined by immunoblotting were 
studied in adjacent histologic sections to calculate the 
percent thyrocytes and percent mitotic cells in the 
sample. At least 200 randomly encountered cells were 
scored as either thyrocytes or  non-epithelial cells 
(principally lymphocytes, fibroblasts and plasma cells). 
Most samples had more than 85% thyroid epithelial 
cells. Sample PTC-1 had approximately 50% non- 
epithelial cells, principally lymphocytes and plasma 
cells. Al1 samples contained far fewer than 1% mitotic 
cells. Ploidy analysis by image analysis of feulgen 
stained smears, or flow cytometry was performed to 
validate the use of total DNA content in the cell lysates 
as a measure of cell number. Al1 but four cases were 
diploid. 
Snap frozen samples, stored at -70 OC, were broken 
under liquid nitrogen into 1-3 mm size fragments, then 
dounced with a tight fitting pestle in approximately 4 
volumes of ice-cold TKM buffer (50 mM TRIS, 5 mM 
MgC12, 2.5 mM KCl, 0.23M sucrose, 6 mM B- 
mercaptoethanol) with freshly added protease inhibitors 
including 1 mM phenylmethylsulphonylfluoride, and 10 
pg/ml each of aprotinin, leupeptin and pepstatin (Sigma, 
St. Louis, MO). The dounced material was filtered 
through a 70  p m  filter (Falcon, Becton-Dickinson, 
Franklin Lakes, NJ) at 4 OC to yield a "crude cell lysate". 
The filtration step removes much of the connective 
tissue. Lamins are so abundant that they were detectable 
by immunoblotting the crude cell lysate. However, to 
load enough nuclear equivalents to detect less-abundant 
nuclear envelope proteins, a "crude nuclear pellet" was 
prepared by low speed centrifugation (750 g for 10  
minutes) at 4 QC followed by re-suspension in TKM 
buffer. To prepare equivalent fractions from HEP2 
hepatocytes, flasks of near confluent HEP2 cells were 
rinsed twice in PBS, then scraped from the plate into ice- 
cold TKM buffer containing protease inhibitors. The 
resulting suspension was  dounced as  above and 
centrifuged at 750 g for 10  minutes to prepare a crude 
nuclear pellet. 
To quantify cell numbers for the lamin immuno- 
blotting experiments, an aliquot of the crude cell lysate 
was mixed with 1% aquaeous toluidine blue to count 
nuclei manually with a hemocytometer. More precise 
cell counts were obtained in subsequent experiments 
(LBR, LAP2 and emerin immunoblotting) by assaying 
an aliquot of material with the DNA-specific dye 
Hoechst 33258 (Sigma, St Louis, MO). Aliquots of 
nuclei were first diluted and lysed in TNE buffer (2.OM 
NaC1, 1 mM EDTA, and 10 mM TRIS-HCl pH 7.4) 
containing 1.0% sodium dodecyl sulfate (SDS) 
(Amresco, Solon, OH). We added 10 microliters of the 
resulting lysate to 2 m1 of 0.1 Wml Hoechst 33258 in 
TNE (without SDS) and analyzed with a TKO 100 
Fluorometer (Hoefer Scientific Instruments, San 
Francisco, CA). The resulting absorbance was translated 
to DNA content by interpolating against a plot of DNA 
standards (calf thymus DNA in 1.0% SDS diluted into 
TNE buffer as above). 
Aliquots of the whole-cell lysate or crude nuclear 
pellets were mixed with SDS-polyacrylamide gel 
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electrophoresis reducing sample loading buffer (final 
concentration 125 mM Tris, pH 6.8, 4.0% SDS, 2% B- 
mercaptoethanol, and 20% glycerol), boiled, sonicated to 
reduce viscosity, and immediately loaded onto 10% 
polyacrylamide minigels. Prelabeled molecular weight 
markers (Gibco BRL Life Technologies, Cat #260 41- 
020, Gaithersburg, MD) were run in adjacent lanes. 
Proteins were transferred to nitrocellulose (Micron 
Separations, Inc, Westborough, MA) by wet blotting 
according to the manufacturers protocol (Amersham, 
Arlington Heights, IL). Immunoblotting and chemi- 
luminescent detection was performed with reagents from 
Amersham according to their protocol. Primary and 
secondary antibodies were diluted into Tris buffered 
saline (20 mM Tris, 137 mM NaCl, pH 7.6) with 0.1% 
Ween-20 and 5% non-fat dry milk. After the primary 
antibody, blots were washed extensively (8 times 30 
minutes) at room temperature in TRIS buffered saline 
with 0.1% 'been-20 to reduce backgound. Under these 
conditions, the following loadings gave signals near the 
middle of the curve of signal intensity versus number of 
nuclei: 5,000-80,000 nuclei for lamin immunoblotting, 
100,000-10,000,000 nuclei for emerin and LBR (using 
HEP2 cells), and 80,000-2,000,000 nuclei for LAP2. 
Results 
lmmunofluorescence detection of nuclear envelope 
proteins in thyroid 
Moderately strong immunostaining intensity was 
achieved with antibodies against lamin A/C, lamin B1, 
Table 1. Cases Studied. 
DIAGNOSIS* AND AGEfiNM 
CASE NUMBER 
% THYROCMES IMMUNOFLUORESCENCE IMMUNOBLOTING 
49 ND** Lamins A. B and C; Emerin; LBR 
90 ND Lamins A, B and C; Emerin; LBR 
85 ND Lamins A, B and C; LBR 
PTC-1 (Tall cell variant) 64n4 NX MX 
PTC-2 70n2 NO MX 
PTC-3 43n3 NX MX 
PTC-4 60n1 NO M0 
PTC-5 74n4 NO MX 
Lamins A, B and C 
Lamins A, B, and C; LBR 
ND 
Lamins A/C and B 
Lamins A and C 
Lamins A and C 
Lamins A/C and B 
Lamins A/C and B; 
Emerin; 414 
Lamins A/C and B; 
Emerin; LAP 2; 41 4 
ND 
ND 
ND 
Lamln B 
ND PTC-9 (Adjacent to an 85n4 NI  b MX 
anaplastic thyroid carcinoma) 
PTC-1 O 33n2 NI  b M0 Lamins A and C; LAP 2 
PTC-11 (Tall cell variant) 50n4 N1 b MX 
PTC-12 65n2 NO MX 
PTC-13 73n2 N 1 a M0 
PTC-14 44n2 N1 b MX 
C-1 27n2 NO M0 
FC-1 (Poorly differentiated, 66n2 N l a  M1 
insular type) 
FC-2 (Hurthle cell type) 4 m 2  NO M0 
Lamins A and C; LAP 2 
Lamins A and C; LAP 2 
Lamins A and C; LAP 2 
LAP 2 
ND 
ND 
Lamins A and C; LAP 2 
Lamins A, B, and C 
Lamins A, B, and C; Emerin; LBR; 
LAP 2 
Lamins A, B. and C; Emeiin; LBR FC-3 52n2 NO MX 
FC-4 (Poorly differentiated, 59n2 NO MX 
insular type) 
FC-5 (Poorly differentiated, 5 W 4  N la  M1 
insular type) 
Lamin A/C 
Lamins A/C and B; 
Emerin; 414 
LAP 2 
ND 
Lamins A and C; LAP 2 
FC-6 (Poorly differentiated) 65n4 NO M1 
FA- 1 55 
ND 
Lamins A, B and C 
Lamins A/C and B; 
Emerin; 41 4 
ND 
Lamins A and C; LAP 2 
Lamins A and C; LAP 2 FA-3 47 
NT-1 (From FC-3 patient) 66 
NT-2 (From PTC-4 patient) 74 
NT-3 (From PTC-7 patient) 60 
NT-4 (Graves disease) 16 
85 ND Lamins A and C; Emerin; LBR 
79 ND Lamins A and C; LBR 
78 Lamins A/C and B Lamins A ,  B and C 
83 ND Lamins A and C. LAP 2 
The diagnoses, age and stage ("TNM"), DNA content ("ploidy", where 1 is diploid) and % thyroid cells in the samples are listed. The TNM (Tumor, Node 
status, Metastasis) stage (Beahrs et al., 1992) corresponds to the time the tissue was procured. Ploidy was determined by flow cytometry on aliquots of 
the procured tissue, or by image analysis on feulgen stained smears. Percent thyrocytes was measured by manually counting cells in a histologic 
section adjacent to the procured tissue. lmmunofluorescence and immunobloiiing were performed with the indicated antibodies. *: Abbreviations for the 
diagnoses (Rosal et al., 1992): PTC, papillary thyroid carcinoma; C, well differentiated thyroid carcinoma not otherwise specified; FC, follicular 
carcinoma; FA, follicular adenorna; NT, non-goiterous, non-inflamed normal thyroid tissue. ND, not done. 
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emerin, and LAP2. The overall staining intensity with 
each antibody was comparable for normal thyroid, 
follicular neoplasms, and PTC samples. The immuno- 
staining patterns for a given specimen were identical 
whether the cells were fixed with formalin or alcohol. 
Table 1 lists the diagnoses, TNM characteristics, 
composition of the tissues, and types of s tudies  
performed. 
lmmunofluorescence distribution of nuclear envelope 
proteins in follicular-type epitheliurn cornpared to PTC 
As controls for the study of the nuclear envelope in 
PTC, we first examined normal thyroid cells and 
follicular neoplasms with relatively spherical nuclei by 
hematoxylin and eosin staining. Dual staining of a 
representative formalin-fixed follicular carcinoma (FC- 
4) with lamin A/C (green) and propidium iodide for 
chromatin (red) is shown in Fig. 1A-C, in a series of 
confocal images separated from each other by 1 micron. 
Note the expected peripheral spherical distribution. 
Slight cell to cell variation in lamin A/C content is 
apparent as noted in other tissues (Chaudhary et al., 
1990; Cance et al., 1992). Identical immunostaining 
patterns were seen in smears of normal thyroid cells 
(data not shown). It is important to note that the confocal 
microscope collects light in a 0.5 p m  thick optical 
section; when the nuclear envelope is perpendicular to 
this optical plane, the intensity would be brighter than if 
the same segment of nuclear envelope were oriented 
parallel to the optical section. Thus, the fluorescence 
signal from the pair of cells in the upper right of Fig. 1A 
is less bright than the same two cells observed in a plane 
near their equator in Fig. 1C. By directly viewing the 
cells and focusing through them, the viewer is able to 
distinguish obliqueness from areas of diminished 
intensity. In the following images, the best area to judge 
immunofluorescence intensity is the plane nearest the 
cell's equator. 
The lamin A/C antibody demonstrates that the 
nuclear envelope of PTC is highly irregular compared to 
the follicular samples. For example, Fig. 1D  shows 
lamin A/C immunostaining (lamins are green, propidium 
iodide stained DNA is red) in an alcohol fixed PTC 
(PTC-9). A large intranuclear cytoplasmic inclusion is 
seen at mid-equatorial leve1 (large arrow). Note that the 
lamin A/C immunostaining is continuous along the 
inclusion, with a staining intensity comparable to the 
opposite, non-deformed side of the nucleus. Another cell 
shows two l ines of increased staining intensity 
(arrowheads in Fig. ID)  that appear to be shallow 
creases or folds of the nuclear envelope, too thin to 
resolve by confocal microscopy. Such lines of lamin 
immunostaining appear to correspond to very thin 
nuclear grooves in corresponding hematoxylin and eosin 
stained smears. A variation in staining intensity of PTC 
samples from cell to cell is obsewed with the lamin A/C 
antibody (Fig. ID)  similar to the variation in the 
follicular samples. 
Lamin B1  immunostaining is more uniform in 
intensity from cell  to cell  in both follicular-type 
epithelium and PTC. Otherwise, its staining pattern is 
similar to that of lamin A/C. Fig. 1E-G shows the 
distribution of lamin B1 in an alcohol-fixed PTC (PTC- 
9) in a series of confocal images separated by 1 pm. The 
fluorescence intensity is continuous along an intra- 
nuclear inclusion (large arrow in Fig. 1F) and throughout 
the full contour of a nuclear groove (cell marked with an 
arrowhead in Fig. 1F). The staining intensity in the 
grooves and inclusions is comparable to the non- 
deformed side of the nucleus. 
Occasional foci of increased staining for nuclear 
envelope proteins are sometimes observed along the 
nuclear periphery in PTC. For example, the cell marked 
with an arrowhead in Fig. 1G has a bright focus that is 
also visible in adjoining sections (Fig. lE,F). These foci 
of bright staining do not correlate with the locations of 
contour irregularity, including grooves or inclusions. 
Dual immunostaining (see below) for lamins, emerin, or 
nuclear pore complexes shows that these bright foci stain 
strongly for multiple antigens. We suspect that these 
bright foci represent highly folded zones in the nuclear 
envelope, rather than an area of increased thickness of 
the lamina itself. 
Flg. 1. Confocal imaging of lamin A/C, larnin 81, and emerin in thryoid neoplasms. For al1 images, red is the propidium iodide staining of chromatin, and 
greenlyellow is the FlTC label for nuclear envelope proteins. Final magnification is 2000, wvering a field of about 37 pm in length. Each wnfocal 
optical section is 0.5 pm in thickness. A-C show the distribution of lamin A/C in a series of confocal images separated from each other by 1 pm in a 
formalin fixed smear of a follicular carcinoma (case FC-4). Note the slight variability from cell to cell in staining intensity, and the round nuclear envelope 
wntour. D shows the lamin A/C distribution in a smear of an alcohol fixed PTC (case PTC-9). Note the continuous distribution of lamin #C across the 
large intranuclear cytoplasmic inclusion (arrow). The staining intensity of lamin A/C in the region of the intranuclear cytoplasmic inclusion is the same as 
the opposite (or convex) sutface of the same ceil's nuclear envelope. One cell has two thin apparent creases (arrowheads) in the nuclear envelope 
(see text). There is some variability in the lamin AIC staining intensity from cell to cell in Fig. ID, similar to the variability in the follicular carcinoma 
sample in Figs. 1A-C. E-G show the lamin B1 distribution in the same alcohol fixed PTC case as in Fig. 1 D (case PTC-9). At least two intranuclear 
cytoplasmic indusions and several grooved cells are present and are displayed in sequential confocal images separated from each other by 1 pm The 
intranuclear cytoplasmic inclusion marked with an arrow in Fig. 1 F can be seen to be lined continuously with lamin B1 at the same relative intensity as 
the convex surface of the same nucleus. Continuous lamin B staining is also seen throughout the depths of a nuclear groove (cell marked with an 
arrowhead in Fig. 1 F) and the intensity of immunostaining in this groove is the same as the more rounded parts of the same cell's nuclear envelope. 
Occasional foci of bright staining are seen, for example the cell marked with an arrow head in Fig. 1 G. These bright foci may represent highly folded 
areas of the nuclear envelope and do not bear any consistent relation to the presence or location of nuclear grooves or inclusions. H shows emerin 
continuously lining the outer perirneter and entirely lining the surface of a large intranuclear inclusion in a single PTC cell (PTC-9) from a formalin fixed 
smear. The staining intensity in the inclusion is the same as the rest of the nuclear envelope. x 2,000 
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In a given thyroid sample, the immunostaining 
pattern of emerin is indistinguishable from that of lamin 
B1. Emerin staining is continuous along al1 parts of the 
nuclear envelope in both PTC and normal thyroid. 
Emerin staining is continuous along a large intranuclear 
cytoplasmic inclusion in Fig. lH, with an intensity equal 
to the rest of the nuclear envelope. A follicular adenoma 
(FA-2) with the typical spherical nuclear shape also 
shows continuous staining along the nuclear envelope 
when immunostained with emerin (Fig. 2B). 
A LAP2 polyclonal antibody raised against amino 
acids 1-187 of human LAP2 showed strong immuno- 
reactivity at the nuclear envelopes of both follicular and 
PTC cells. The LAP2 immunostaining pattern is 
indistinguishable from that of lamin B1 or emerin. LAP2 
immunofluorescent staining of a formalin fixed PTC 
(PTC-14) is shown in Fig. 2A. Again, continuous 
staining of the nuclear periphery, and continuous 
staining of an intranuclear cytoplasmic inclusion 
(arrowhead) are seen. The intensity of LAP2 immuno- 
staining is the same in the relatively spherical parts of 
the nuclear envelope as it is in grooves and inclusions. 
Antibody 414, recognizing an epitope common to a 
number of nuclear pore proteins, gave a finely punctate 
staining pattern along the nuclear envelope of both PTC 
(PTC-14, Fig. 2C) and follicular epithelium (FA-2, a 
follicular adenoma, Fig. 2D). Nuclear pore complexes 
are not excluded from either the intranuclear 
cytoplasmic inclusions or grooves of PTC nuclei. 
We considered the possibility that a subset of the 
nuclear envelope irregularities in PTC might lack 
nuclear envelope structural protein(s), and therefore 
would be difficult to detect. This appears unlikely for the 
foliowing reasons: First, nuclear envelope irregularities 
are independently revealed by the propidium iodide 
counterstain. In al1 PTC samples, the distribution of 
nuclear envelope proteins was continuous with the 
propidium iodide-stained outer edge of chromatin. 
Second, dual immunostaining for lamins A/C or B1, 
with either emerin or nuclear pore complexes showed 
Flg. 2. Confocal imaging of LAP 2, emerin, and nuclear pores in thyroid neoplasms. A shows a formalin fixed PTC sample (case PTC-10) stained with 
an antibody raised against an epitope shared by al1 known LAP2 isoforms. Note the continuous, even staining pattern around the highly irregular 
nuclear contour, and the staining of a small intranuclear cytoplasmic inclusion (arrowhead). B shows the emerin immunostaining pattern in a forrnalin 
fixed follicular adenoma (FA-2). C and D show the nuclear pore distribution in formalin fixed PTC cells and follicular adenomas (cases PTC-10 and FA- 
2, respectively). Nuclear pores can be seen to follow the entire irregular nuclear contour of PTC. x 2,000 
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that nuclear envelope proteins always colocalized in PTC 
(not shown). This  analysis would have disclosed 
domains of the nuclear envelope devoid of one nuclear 
envelope protein. Finally, the degree and quality of the 
nuclear irregularity in hematoxylin and eosin stained 
smears of these PTC samples was comparable to the 
immunostained appearance of the nuclear envelope. 
Electrophoretic mobility and relative abundance of lamins 
A, C and B1 
Immunoblotting showed that the electrophoretic 
mobilities of lamins A, C, and B1 are the same in PTC 
and follicular thyroid samples (Figs. 3A,B). The 
calculated molecular weights are approximately 72 kD 
for lamin A, 62 kD for lamin C, and 67 kD for lamin B. 
By loading known numbers of nuclei (see Methods), we 
estimated the relative amounts of each lamin per cell. 
For each sample, three different numbers of nuclei were 
run, and for a given comparison, al1 samples were 
blotted, probed, and developed together. Lamins A, C 
and B1 al1 become detectable at 5,000 to 20,000 nuclei 
per lane (Figs. 3A,B). In the series shown, PTC tends to 
have more lamin A/C than normal thyroid or follicular 
adenomas, a finding opposite to predictions in the 
literature that lamin A/C content should be lower in 
proliferating cells (Chaudhary et al., 1990; Cance et al., 
1992; reviewed in Bosman, 1996; Coates et al., 1996). In 
other experiments, some follicular neoplasms had more 
lamin A/C than the PTC samples to which they were 
compared (not shown). Overall, there was no correlation 
between lamin A/C content and clinical or pathological 
features. 
We noted that the ratio of lamin A and C band 
intensities was not always equal. For example lamin A 
appeared slightly less abundant than lamin C in PTC-6 
(Fig. 3A). In addition, some faint lower molecular 
weight bands are seen in PTC-6 and PTC-7. These may 
represent degradation, since this pattern could be 
reproduced by processing the thawed tissue at room 
temperature rather than on ice (not shown). The altered 
ratio of lamin A to C was also sometimes observed in 
follicular samples. A low ratio of larnin A to C has been 
observed in other tissues, including erythroid precursor 
cells (Martelli et al., 1992), and embryonal carcinoma of 
the testis (Machiels et al., 1997). 
Electrophoretic mobility and relative amount of emerin 
The electrophoretic mobility of emerin is identical 
for al1 samples studied (Fig. 3C), and is calculated to be 
34 kD. There is no consistent difference in the relative 
amount of emerin between PTC and follicular samples. 
Sparse or absent LBR in the thyroid 
An affinity-purified antibody against human LBR 
detected a single band of the appropriate size (-58 kD) 
in HEP2 cells, a human hepatocyte cell line (Fig. 3D). 
This band was detectable when loading as  few as 
100,000 nuclei. In contrast, LBR was not detected when 
loading 10,000,000 nuclei from thyroid samples, with 
one exception: case PTC-1, which contains a high 
proportion of non-thyroid cells, displayed a distinct 
single 58  kD band at high nuclear loadings in longer 
exposures (not shown). The same nuclear preparations 
contain an appropriate amount of non-degraded lamins 
by immunoblotting (data not shown), demonstrating that 
the quantification of nuclei was correct and that the 
samples were not proteolytically degraded. We conclude 
that immunoreactive LBR, if it is present at al1 in thyroid 
cells, is expressed at less than 1% of the leve1 in HEP2 
hepatocytes per cell .  Since some of our samples 
contained a significant proportion of admixed 
lymphocytes, plasma cells, and stromal cells (see Table 
l), the abundance of LBR also appears to be low in these 
non-thyroid cells, compared to HEP2 cells. 
LAP2 isoforms NI the thyroid 
The LAP2 antibody specifically recognized three 
major bands of approximately 76,54 and 38 kD in HEP2 
cells and thyroid samples. Five representative thyroid 
samples probed with LAP2 antibody are shown in Fig. 
3E. The three principal bands correspond closely to the 
expected masses of the known LAP2 isoforms -a, B, and 
y. Two other minor bands of about 50 and 40 kD were 
also seen in some samples. No bands were detected with 
pre-immune serum from rabbit #2804 (not shown). 
There is some variation in the relative intensities of the 
bands, but with no correlation to clinicopathologic 
features. The 76 kD band is not evident in sample PTC- 
12  at the exposure shown, but is evident with longer 
exposure (not shown). Of two follicular adenomas 
studied, one (FA-3) had a relatively weak 38 kD band 
(Fig. 3E), and the other (FA-2) had a relatively strong 38 
kD band (not shown). 
Attempts to purify PTC nuclei in sucrose gradients 
As a first step in producing purified PTC nuclear 
envelopes, we attempted to purify nuclei using high 
speed sedimentation of crude nuclear pellets in 2.3M 
sucrose, according to a standard protocol for isolating 
pure hepatocyte nuclei (Dwyer and Blobel, 1976). 
Purified thyroid cell nuclei were isolated from crude 
nuclear pellets with yields >40% in four of four attempts 
from normal thyroid and follicular neoplasms, but the 
yield of purified nuclei from PTC samples was very low 
in two of three attempts (data not shown). This may be 
due to a buoyancy of the PTC nuclei. Repeat 
sedimentation of fewer cells in 1.8M sucrose solutions 
did not improve percent yield. Variation in the 
"buoyancy" of nuclei of different cell types has been 
previously observed (Pederson and Spann, 1998). The 
PTC nuclei that sedimented were morphologically 
indistinguishable from the nuclei of non-sedimenting 
PTC cases. Interestingly, sucrose-purified unfixed nuclei 
Lamln A- - m '  - 
- 
Lamln C- - - - 
LBR- 
Flg. 3. lmmunoblotting of lamins, emerin, lamin B receptor and LAP2 proteins. Representative results of a survey of nuclear envelope proteins is 
shown. For a given antibody, known numbers of nuclei (shown above each lane x 10-3) were loaded, electrophoresed, immunoblotted, and exposed 
together to allow comparison of the relative amounts on a per cell basis. The molecular weights were measured against pre-stained molecular weight 
standards loaded onto the same gels. The calculated molecular weights, in accordance with previous reports, are 72 and 62 kD for lamins A and C (A), 
67 kD for larnin B (B), 34 kD for emerin (C), 58 kD for lamin B receptor (D), and 76, 54 and 38 kD for the a, B and y isoforms of LAP2 (E). For lamin B 
receptor, a very faint band at the expected molecular weight of 58 kD is apparent when loading 100,000 HEP2 (human hepatocyte) nuclei, whereas no 
bands are apparent when loading up to 10,000,000 nuclei of any of the thyroid samples at the exposure shown. For each of the other antibodies. the 
relative amounts and electrophoretic mobilities overlap between PTC and follicular samples. The LAP2a band is not evident in the PTC-12 sample at 
the exposure shown, but is apparent at longer exposures. Possible minor isoforms of LAP2 proteins are also seen in al1 the samples shown in this Fig. 
(see text) . 
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from frozen tissue, stripped of cytoplasm, retain the 
distinctive nuclear contour features of either follicular 
neoplasms or PTC. 
Discussion 
Our study suggests that the irregular nuclear contour 
of papillary thyroid carcinoma is not due to alterations in 
the expression or localization of lamins, emerin, LAP2 
or LBR. Specifícally, intranuclear cytoplasmic inclusions 
or grooves do not result from a localized deficiency of 
any of the structural envelope proteins studied, nor is 
there any obvious alteration in the distribution of lamins, 
LAP2, emerin, or nuclear pore complexes with respect to 
the nuclear contour alterations in PTC. The distribution 
of these major nuclear envelope proteins appears simply 
to conform to the contour of the irregular nucleus in 
PTC. The relative abundance and electrophoretic 
mobility of the nuclear lamina proteins did not differ 
between PTC and follicular-type epithelium. These 
results are surprising since the nuclear lamina appears to 
play a central role in defining nuclear shape. For 
example, expression of mutant lamins, o r  altered 
expression of lamins or LAP2 affects nuclear contour 
(Loewinger and McKeon, 1988; Furukawa and Hotta, 
1993; Ellis et al., 1997; Lenz-Bohme et al., 1997). Very 
recent studies in C.elegans confirms a role for lamins in 
defining nuclear shape: timelapse video imaging 
demonstrates that the contour of lamin-deficient nuclei 
of C. elegans changes significantly and rapidly, every 30 
seconds, in living embryonic cells (Y. Gruenbaum, 
personal communication). Lamins rnay therefore be 
required for nuclei to resist deforming forces that arise 
continuously either from inside or outside the nucleus. 
We did not study lamin B2 or LAP1, and our analysis 
cannot exclude subtle electrophoretic mobility changes 
in the six proteins that were studied. Nevertheless, in the 
absence of detectable changes in the expression of six 
principle nuclear envelope proteins, we  think i t  
reasonable to consider alternative hypotheses for the 
changes in nuclear shape of PTC cells: nuclear contour 
rnay be controlled by a balance between forces exerted 
on the nuclear envelope from the inside @y chromatin or 
the nuclear matrix) and the outside (cytoskeleton). We 
hypothesize that this balance is disturbed in PTC cells. 
We speculate this balance rnay be actively regulated in 
certain cell types, such as white blood cell precursors, in 
which the shape of the nucleus changes dramatically 
during differentiation. 
Chromatin and nuclear matrix proteins rnay directly 
influence nuclear contour, for two reasons. First, PTC 
nuclei stripped of cytoplasm appear to retain their shape 
irregularities. Second, RETIPTC is known to affect 
chromatin as well as the nuclear envelope (Fischer et al., 
1998a) and PTC itself shows both chromatin as well as 
nuclear envelope changes. If chromatin effects a change 
in the shape of the nuclear envelope, it is not apparently 
due to gross changes in the chromatin-associated 
proteins LBR, LAP2, or emerin. The nuclear matrix is 
the complex biochemical fraction that remains after 
extraction with deoxyribonuclease, non-ionic detergent 
and salt. Electron microscopy of resinless sections of the 
nuclear matrix displays filaments that physically contact 
the nuclear lamina (reviewed by Nickerson, 1998). The 
nature of these nuclear matrix filaments is not well 
understood. They rnay include lamins themselves, since 
some lamins have been found within the nuclear interior 
in many organisms (Moir et al., 1995; Paddy et al., 1996; 
Y. Gruenbaum, personal communication). Another 
chromatin-associated protein that rnay influence nuclear 
contour is actin, which has been unequivocally localized 
in the nucleus (reviewed by Rando et al., 2000). Nuclear 
actin rnay have a predominantly peripheral distribution 
(Clubb and Locke, 1998), perhaps as a consequence of 
binding to lamin A (Sasseville and Langelier, 1998). 
The cytoskeleton can influence nuclear contour. For 
example cell lines that lack cytoplasmic intermediate 
filaments have more irregular nuclear contours than the 
same cell  l ines in which intermediate filament 
expression has been restored, suggesting that the 
cytoskeleton is able to constrain nuclear contour (Sama 
et al., 1994) (however, see conflicting results of Holwell 
et al., 1997). Expression of mutant keratins causes 
abnormalities in nuclear shape (Fuchs et al., 1992). 
Furthermore, bundles of cytoplasmic intermediate 
filaments have been observed within nuclear folds in a 
pancreatic adenocarcinoma cell line, and have appeared 
to physically indent the nucleus (Kamei, 1994). Direct 
micromanipulation of integrins at the plasma membrane 
deforms the nucleus, and even causes movement of 
nucleoli (Maniotis et al., 1997). Nuclei are frequently 
indented next to the centrosome (e.g. Shu and Joshi, 
1995), as if the microtubule system that they organize 
pushes on the nuclear envelope. Resinless section 
electron microscopy has demonstrated cytoplasmic 
filaments that appear to directly attach to the nuclear 
lamina (reviewed in Nickerson, 1998). However, the 
molecular basis for interactions of the cytoskeleton with 
the nuclear envelope remains obscure (Goldman et al., 
1985; Georgatos and Blobel, 1987; Albers and Fuchs, 
1989). 
Potential functional significance of altered nuclear 
envelope contour in cancer 
The fact that nuclear contour changes are so  
common in cancer cells, often from an early stage in 
cancer development, and that they appear conserved 
during the subsequent evolution of cancer cells should 
indicate that alterations in nuclear contour are 
functionally significant. Severa1 nuclear envelope 
proteins appear to affect replication competance, 
including lamins A/C, B, and LAP2. B-type lamins are 
strongly implicated in positively regulating DNA 
replication, as  demonstrated in "artificial" nuclei. 
"Artificial" nuclei can be assembled around sperm 
chromatin using nuclear envelope-derived vesicles from 
meiot ic  Xenopus egg extracts.  When lamin B i s  
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immunodepleted from these egg extracts, the nuclei are 
unable to replicate (Newport et al., 1990; Jenkins et al., 
1993). Replication competence in this model is 
specifically restored by re-addition of lamin B (Goldberg 
et al., 1995). The mechanism by which lamin B may 
influence replication competence is unknown. Of 
possible relevance is the ñnding that a fraction of B type 
lamins are present in intranuclear foci that colocalize 
during S-phase with sites of replication (Moir et al., 
1994). Dominant disrupting mutant lamin proteins- 
which disturb the normal peripheral rim distribution of 
lamin B-also diminish or prevent replication (Ellis et 
al., 1997; Spann et al., 1997). Supporting the hypothesis 
that lamin B is important in determining replication 
competence is the obsewation that its expression tends 
to be higher in stem cells (Broers et al., 1997; Machiels 
et al., 1997) compared to terminally differentiated cells. 
In contrast to B-type lamins, the expression of 
lamins A and C is implicated in loss of replication 
competance and terminal differentiation (reviewed in 
Moir et al., 1995; Bosman, 1996). For example, crypt 
cells of the intestines and basa1 keratinocytes do not 
express lamin A/C, whereas cells higher in the crypts or 
epidermis do express lamins A/C (Chaudhary et al., 
1990; Cance et al., 1992; Coates et al., 1996). Lamins 
A/C can interact with the retinoblastoma (Rb) gene 
product in vitro, and they partly colocalize with Rb in 
vivo, leading to speculation that lamins A/C may 
infiuence Rb function (Mancini et al., 1994). 
LAP2 may also regulate DNA replication 
competence: when "artificial" assembling nuclei are 
exposed to exogenous LAP2B polypeptides, either in 
vitro or by microinjection into post-mitotic cells, nuclear 
growth is inhibited (Yang et al., 1997; Gant et al., 1999). 
When added to assembling nuclei in Xenopus extracts at 
low micromolar concentrations, LAP2B can increase the 
efficiency of DNA replication (Gant et al., 1999); 
however replication is inhibited by higher concentrations 
of LAP2B (Yang et al., 1997; Gant et al., 1999). A study 
of LAP2 expression in adult rat tissues showed tissue- 
specific expression of LAP2 isoforms, with some 
tendency for higher LAP2B expression in tissues with 
high proliferative activity (Ishijima et al., 1996). 
We found no relation between the relative amounts 
of lamin A/C, B1 or LAP2 proteins and clinico- 
pathological features predictive of replication rate in the 
thyroid. In fact, the average amount of lamin A/C per 
cell appears sometimes higher for follicular neoplasms 
or PTC than normal non-neoplastic thyroid (Fig. 3A). 
An immunohistochemical study also showed that 
normal, regenerating, and neoplastic hepatocytes al1 
express lamin A/C (Hytiroglou et al., 1993). Although 
the amounts of these nuclear lamina proteins appear 
unaltered, the increased nuclear envelope surface area of 
PTC might influence replication competence, through 
more extensive contacts between the envelope and 
chromatin. Furthermore, since there was cell-to-cell 
variability in lamin A/C staining intensity in our samples 
(e.g. Figs. 1A-D), we cannot exclude the possibility that 
replication competance is retained selectively in 
neoplastic thyroid cells with diminished lamin A/C 
content. 
LBR had been thought to be widely expressed, but 
we found that LBR, if it is expressed at al1 in the thyroid, 
is present at less than 1% the leve1 of hepatocytes. The 
absence or paucity of LBR in the thyroid suggests that 
its proposed roles in targeting postmitotic nuclear 
envelope vesicles to chromatin (Pyrpasopoulou et al., 
1996), or organizing heterochromatin at the nuclear 
envelope (Ye et al., 1998) can be performed by other 
proteins. 
The thyroid as a model for studying large scale nuclear 
organization 
The study sample in Table 1 demonstrates the 
usefulness of the thyroid as a model for studying the 
molecular basis of diagnostic structural changes in 
cancer cells. Normal and tumorous crude thyroid 
samples are relatively homogeneous, typically with 
about 85% tumor cells and only rare mitotic figures. 
Most thyroid tumors are diploid, alleviating the 
problems of genetic instability and tumor cell 
heterogeneity that plague studies of other common solid 
tumors. Since their histogenesis is the same, the 
molecular features of PTC and foliicular neoplasms can 
be readily compared. The two pathways that transform 
normal thyroid epithelial cells are genetically distinct, 
and the morphologic features associated with these two 
pathways can be reproduced in an in vitro model system 
(Bond et al., 1994; Fischer et al., 1998a). 
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